Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Shalini Sharp currently holds 15,000 shares of ANTIGENICS INC /DE/ (AGEN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Shalini Sharp has been a net seller of AGEN stock. They have purchased $114.1K and sold $18.3M worth of shares.
Shalini Sharp's most recent insider trade was on Jun 26, 2026, when they sold 15,000 shares at $0.00 per share.
Shalini Sharp serves as Executive at ANTIGENICS INC /DE/ (AGEN). They have executed 172 insider transactions totaling $18.4M over their tenure at the company.
Shalini Sharp holds the position of Executive at ANTIGENICS INC /DE/, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Shalini Sharp has shown a selling trading pattern, with $114.1K in total purchases and $18.3M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Shalini Sharp was on May 18, 2020, when they sold $1.4M worth of RARE shares. This transaction involved 19,593 shares at $73.34 per share.
Shalini Sharp currently owns 15,000 shares of ANTIGENICS INC /DE/ (AGEN), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Shalini Sharp's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Shalini Sharp has 172 Form 4 filings on record as an insider at ANTIGENICS INC /DE/.
Set alerts for Shalini Sharp and 40,000+ other insiders.